EA200601392A1 - Способы и композиции для лечения липодистрофии - Google Patents
Способы и композиции для лечения липодистрофииInfo
- Publication number
- EA200601392A1 EA200601392A1 EA200601392A EA200601392A EA200601392A1 EA 200601392 A1 EA200601392 A1 EA 200601392A1 EA 200601392 A EA200601392 A EA 200601392A EA 200601392 A EA200601392 A EA 200601392A EA 200601392 A1 EA200601392 A1 EA 200601392A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- lipodystrophy
- methods
- treatment
- compositions
- hiv
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54020404P | 2004-01-29 | 2004-01-29 | |
US54336604P | 2004-02-10 | 2004-02-10 | |
PCT/EP2005/000758 WO2005074916A1 (en) | 2004-01-29 | 2005-01-26 | Methods and compositions for the treatment of lipodystrophy |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200601392A1 true EA200601392A1 (ru) | 2006-12-29 |
Family
ID=34841102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200601392A EA200601392A1 (ru) | 2004-01-29 | 2005-01-26 | Способы и композиции для лечения липодистрофии |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1722778A1 (ja) |
JP (1) | JP2007519669A (ja) |
KR (1) | KR20060127977A (ja) |
AU (1) | AU2005210093A1 (ja) |
BR (1) | BRPI0507302A (ja) |
CA (1) | CA2552404A1 (ja) |
EA (1) | EA200601392A1 (ja) |
IL (1) | IL176762A0 (ja) |
NO (1) | NO20063279L (ja) |
WO (1) | WO2005074916A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2903312B1 (fr) | 2006-07-05 | 2008-09-26 | Univ Aix Marseille Ii | Utilisation d'inhibiteurs d'hmg-coa reductase et de farnesyl-pyrophosphate synthase dans la preparation d'un medicament |
AU2008353145B2 (en) * | 2008-01-03 | 2013-09-12 | Universite D' Aix-Marseille | Bitherapy and tritherapy used for treating an HIV-positive patient |
US20100267636A1 (en) * | 2009-04-20 | 2010-10-21 | Theratechnologies Inc. | Use of cytochrome p450-metabolized drugs and grf molecules in combination therapy |
JP6712230B2 (ja) * | 2014-03-11 | 2020-06-17 | ノバルティス アーゲー | リポジストロフィーおよびインスリン産生の欠損またはインスリンシグナル伝達の欠損と関連する代謝性障害を処置する方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9803623D0 (sv) * | 1998-10-22 | 1998-10-22 | Sahltech Ab | New therapeutic application |
-
2005
- 2005-01-26 BR BRPI0507302-2A patent/BRPI0507302A/pt not_active IP Right Cessation
- 2005-01-26 EP EP05707019A patent/EP1722778A1/en not_active Withdrawn
- 2005-01-26 CA CA002552404A patent/CA2552404A1/en not_active Abandoned
- 2005-01-26 JP JP2006550092A patent/JP2007519669A/ja active Pending
- 2005-01-26 WO PCT/EP2005/000758 patent/WO2005074916A1/en active Application Filing
- 2005-01-26 AU AU2005210093A patent/AU2005210093A1/en not_active Abandoned
- 2005-01-26 EA EA200601392A patent/EA200601392A1/ru unknown
- 2005-01-26 KR KR1020067016376A patent/KR20060127977A/ko not_active Application Discontinuation
-
2006
- 2006-07-10 IL IL176762A patent/IL176762A0/en unknown
- 2006-07-14 NO NO20063279A patent/NO20063279L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2005074916A1 (en) | 2005-08-18 |
NO20063279L (no) | 2006-09-19 |
JP2007519669A (ja) | 2007-07-19 |
KR20060127977A (ko) | 2006-12-13 |
CA2552404A1 (en) | 2005-08-18 |
EP1722778A1 (en) | 2006-11-22 |
AU2005210093A1 (en) | 2005-08-18 |
IL176762A0 (en) | 2006-10-31 |
BRPI0507302A (pt) | 2007-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
ATE489957T1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
MX2007011545A (es) | Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr. | |
EA201390772A1 (ru) | Новые соли и полиморфные формы афатиниба | |
MA33806B1 (fr) | Inhibiteurs du virus de l'hepatite c | |
EA200700225A1 (ru) | Аналоги тетрапептида | |
EA200870569A1 (ru) | Соединения и способы модуляции fxr | |
EA200601776A1 (ru) | Метадоновые композиции местного действия и способы их применения | |
EA201000914A1 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
MX349188B (es) | Sns - 595 y metodos para utilizar el mismo. | |
EA200900802A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
NZ593474A (en) | Compositions and methods for treatment of celiac disease | |
BRPI0508390B8 (pt) | uso de um anticorpo antagonista anti-ngf, bem como kit e composição farmacêutica para tratamento de dor de câncer de osso | |
EA201300116A1 (ru) | Антагонисты активина-actriia и применение для стимуляции роста кости у больных раком | |
EA200600078A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
ATE495739T1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
EA201290322A1 (ru) | Лечение желудочно-кишечных расстройств | |
EA201290356A1 (ru) | Композиции для лечения тошноты и рвоты центрального происхождения | |
EA201001749A1 (ru) | Способ лечения недифференцированного артрита | |
EA201300421A1 (ru) | Комбинированная терапия для лечения инфекции hcv | |
EA201400423A1 (ru) | Фармацевтические препараты и их применение при лечении половой дисфункции у женщин | |
ATE555108T1 (de) | Polyamide zur behandlung des menschlichen papilloma-virus | |
EA201200428A1 (ru) | Композиция и способ для лечения ожирения |